Last reviewed · How we verify

NCT04922879

Early Lung Rehabilitation Care for Patients After Double Lung Transplantation

Completed NA Last updated 11 June 2021
What this trial tests

NA trial testing Individualized lung rehabilitation in Pulmonary Disease in 12 participants. Completed in 30 March 2020.

Timeline
1 May 2018
Primary endpoint
31 December 2019
30 March 2020

Quick facts

Lead sponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment12
Start date1 May 2018
Primary completion31 December 2019
Estimated completion30 March 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

18 and older, any sex, with Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Develop appropriate individual programs for patients to implement lung rehabilitation safely and effectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pulmonary Disease

Currently open trials in the same condition.

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04922879.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing